Today’s guest post comes from Lara Loveman, VP of Pharma Solutions at Outcomes.
Lara discusses how shifting market forces and evolving reimbursement models are reshaping pharmaceutical marketing strategies. She suggests that pharmacist-led interventions—particularly in chronic disease management—can both protect pharmaceutical investment and drive better health outcomes.
Click here to learn about Outcomes’ pharmacist-led interventions solution.
Read on for Lara’s insights.
Read more »
Source: Post feed
